# Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

> **NCT02100371** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 2 (actual)

## Conditions studied

- Basal Cell Nevus Syndrome

## Interventions

- **DRUG:** BMS-833923

## Key facts

- **NCT ID:** NCT02100371
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02100371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02100371, "Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02100371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*